title: [Antiphospholipid-syndrome - when to treat?].
authors.affiliation: Abteilung für Rheumatologie und Klinische Immunologie, Zentrum für Innere Medizin, Kliniken Essen Süd. specker@rheumanet.org
authors.forename: Ch
authors.initials: Ch
authors.lastname: Specker
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D017152:Antibodies, Antiphospholipid / Q000097:blood; D016736:Antiphospholipid Syndrome / Q000175:diagnosis* / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000188:drug therapy; D013923:Thromboembolism / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D017152:Antibodies, Antiphospholipid; D005343:Fibrinolytic Agents; D016682:Lupus Coagulation Inhibitor; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin